Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-62961
Pelkmans, L; de Laat, B (2012). Antibodies against domain I of β2-glycoprotein I: the one and only? Lupus, 21(7):769-772.
PDF - Registered users only
View at publisher
The antiphospholipid syndrome (APS) is diagnosed by the occurrence of thrombosis and/or specific pregnancy morbidity. However, the diagnosis of APS is not easy and is hampered by several problems including high prevalence of clinical symptoms and high variability between different assays resulting in a high false-positive rate. Currently APS can be diagnosed for example by detecting anti-β2-glycoprotein I antibodies by ELISA. It has been reported that β2-glycoprotein I (β2GPI) changes its conformation from a native to an active form and thereby it opens up enabling antibodies to bind a specific epitope. We amongst others have shown that epitope glycine40-arginine43 of domain I of β2GPI is predominantly responsible for binding thrombosis related antibodies. Antibodies with affinity towards other epitopes have not been associated with thrombosis. Despite these results the question remains whether these domain I antibodies are the only antibodies of importance for the detection of APS.
1 download since deposited on 04 Jul 2012
0 downloads since 12 months
|Item Type:||Journal Article, refereed, original work|
|Communities & Collections:||07 Faculty of Science > Institute of Molecular Life Sciences|
|DDC:||570 Life sciences; biology|
|Deposited On:||04 Jul 2012 07:40|
|Last Modified:||30 Nov 2013 18:35|
Users (please log in): suggest update or correction for this item
Repository Staff Only: item control page